List of Valsoft Anju TrialMaster Customers
Montreal, H4T 1Z2, QC,
Canada
Since 2010, our global team of researchers has been studying Valsoft Anju TrialMaster customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Valsoft Anju TrialMaster for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Valsoft Anju TrialMaster for Clinical Trial Management include: Gustave Roussy France, a France based Healthcare organisation with 3200 employees and revenues of $420.0 million, Symbio, a United States based Life Sciences organisation with 188 employees and revenues of $38.0 million, Fgk Clinical Research, a Germany based Life Sciences organisation with 170 employees and revenues of $30.0 million and many others.
Contact us if you need a completed and verified list of companies using Valsoft Anju TrialMaster, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Valsoft Anju TrialMaster customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fgk Clinical Research | Life Sciences | 170 | $30M | Germany | Valsoft Corporation | Valsoft Anju TrialMaster | Clinical Trial Management | 2019 | n/a |
In 2019, FGK Clinical Research implemented Valsoft Anju TrialMaster for Clinical Trial Management to support its CRO operational and clinical data management services in Munich, Germany. The agreement established a five-year deployment to provision Valsoft Anju TrialMaster alongside complementary eClinical modules across FGK study operations.
The implementation included TrialMaster EDC, IRTMaster, and Acuity Analytics, with configuration work focused on EDC case report form management, randomization and drug supply orchestration through IRTMaster, and centralized reporting via Acuity Analytics. Onboarding and system configuration were managed locally with professional services support from OmniComm Anju, aligning product setup to FGK clinical data management workflows.
Integrations emphasized tighter EDC to IRT data flows to reduce redundant data entry and streamline site workflows, placing operational coverage on clinical data management and site operations across FGK's trial portfolio. Governance and rollout were coordinated through local onboarding activities and professional services oversight, enabling synchronized site activation and consistent EDC configuration while improving data orchestration between EDC and IRT systems.
|
|
|
Gustave Roussy France | Healthcare | 3200 | $420M | France | Valsoft Corporation | Valsoft Anju TrialMaster | Clinical Trial Management | 2017 | n/a |
In 2017 Gustave Roussy France implemented Valsoft Anju TrialMaster as its Clinical Trial Management platform to centralize oncology clinical trial data across its Paris-area campuses. The deployment positioned TrialMaster EDC as the primary system for managing complex study designs, including umbrella, basket, and other platform trials in oncology research.
The implementation emphasized electronic data capture and study configuration capabilities typical of Clinical Trial Management systems, enabling protocol-driven CRF construction, data validation, and query workflows for multicohort oncology protocols. Valsoft Anju TrialMaster was configured to support complex study schemas and iterative protocol amendments common to platform trial operations.
Operational coverage extended to clinical operations, data management, and study teams at Gustave Roussy’s Paris-area sites, supporting end-to-end oncology study conduct and readiness for regulatory submission. The deployment served as the authoritative EDC for trial data capture and study submission preparation, with TrialMaster integrated into routine research operations rather than as a point solution.
Gustave Roussy renewed its TrialMaster contract in January 2022 after five years of use, with the renewal noting improved efficiency, scalability, and faster study submission readiness in oncology research. The renewal underscores continued governance and operational commitment to Valsoft Anju TrialMaster as the core Clinical Trial Management system for complex oncology trials.
|
|
|
Symbio | Life Sciences | 188 | $38M | United States | Valsoft Corporation | Valsoft Anju TrialMaster | Clinical Trial Management | 2019 | n/a |
In 2019, Symbio deployed Valsoft Anju TrialMaster as its Clinical Trial Management solution under a five-year agreement to use OmniComm's TrialMaster EDC. The initiative was scoped to develop and manage clinical study databases for Symbio's global CRO services and to support the company’s European expansion, with selection drivers including fast study-build capability and reliable randomization.
Valsoft Anju TrialMaster was configured to support electronic data capture workflows, rapid study-build processes, electronic case report form generation, and integrated randomization functionality. Configuration emphasis was placed on reusable CRF templates, standardized study-build procedures, and streamlined database update paths to enable submission-ready CRFs for sponsor clients.
Operational coverage included Symbio’s clinical operations and data management functions across its U.S. base and expanding European activities, aligned under the five-year contract governance. The rollout prioritized centralized build standards and sponsor deliverable readiness, aiming to deliver faster database builds, easier updates, and submission-ready CRFs for sponsor clients.
|
Buyer Intent: Companies Evaluating Valsoft Anju TrialMaster
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||